Clinical Trial Update: Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating OROS methylphenidate for college students with ADHD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• OROS-Methylphenidate (methylphenidate, osmotic release formulation)

Snippet

Sponsor: University of Pittsburgh | Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) | Phase 4 | Status: WITHDRAWN